NexGen Jane is a women's health company leveraging data to provide women with insight into reproductive health through a smart tampon diagnostic system. The smart tampon can track changes predictive of diseases such as cervical cancers and more, from the user's home.
Diagnostic testing is performed by mailing cells collected, via the tampon, from the reproductive tract during menstruation. Those cells are then tested and studied, creating an alternative diagnostic test to a traditional Pap Smear.
Timeline
April 1, 2019
NexGen Jane raises a $9,000,000 series A round from Access Industries, Liminal Ventures, Material Impact and Viking Global Investors.
April 2019
NexGen Jane raises a $9,000,000 series A round from Access Industries, Liminal Ventures, Material Impact and Viking Global Investors.
March 10, 2016
NexGen Jane raises a $2,200,000 venture round.
Funding rounds
Patents
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
Connie Loizos
April 1, 2019
TechCrunch
There's no shortage of so-called femtech startups raising money right now, and it's little wonder why. Aside from the growing market opportunity -- the global fertility services market is expected to reach $31 billion by 2023, says the consultancy Allied Market Research, nearly dou...
References
Organization
CompanyCompany attributes
Laboratory
Healthcare
Women's Health
Medical diagnostics
BiotechnologyLocation
Oakland, CaliforniaCompany Operating Status
Active
B2X
B2CFounder
Pitchbook URL
Full address
1090 63rd Street, Unit 4, Oakland, CA, 94608, United States
Access Industries
Viking Global Investors
Material ImpactFounded date
2014
Email address
jane@nextgenjane.com
Phone number
+12726480794
Total funding amount (USD)
20,200,000
Latest funding round date
April 1, 2019
Latest funding type
Series A round
